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The gut epithelium self-renews every several
days, providing an important innate defense
system that limits bacterial colonization. Never-
theless, many bacterial pathogens, including
Shigella, efficiently colonize the intestinal epithe-
lium. Here, we show that the Shigella effector
IpaB, when delivered into epithelial cells, causes
cell-cycle arrest by targeting Mad2L2, an ana-
phase-promoting complex/cyclosome (APC) in-
hibitor. Cyclin B1 ubiquitination assays revealed
that APC undergoes unscheduled activation
due to IpaB interaction with the APC inhibitor
Mad2L2. Synchronized HeLa cells infected with
Shigella failed to accumulate Cyclin B1, Cdc20,
and Plk1, causing cell-cycle arrest at the G2/M
phase in an IpaB/Mad2L2-dependent manner.
IpaB/Mad2L2-dependent cell-cycle arrest by
Shigella infection was also demonstrated in
rabbit intestinal crypt progenitors, and the IpaB-
mediated arrest contributed to efficient coloni-
zation of the host cells. These results strongly
indicate that Shigella employ special tactics to
influence epithelial renewal in order to promote
bacterial colonization of intestinal epithelium.
INTRODUCTION
Shigella are highly adapted human pathogens that cause
bacillary dysentery, a disease that provokes severelybloody and mucous-containing diarrhea. Shigella belong
to the Escherichia coli family, but unlike other pathogenic
E. coli, Shigella have no adherence factors. Thus, follow-
ing ingestion via the fecal-oral route,Shigella reach the co-
lon and rectum and translocate through the epithelial bar-
rier via M cells overlying solitary lymphoid nodules. Once
they pass through the M cells, Shigella infect the resident
macrophages and escape from the macrophages’ phago-
somes into the cytoplasm, where they multiply and induce
rapid cell death (Sansonetti, 2004; Ogawa and Sasakawa,
2006). Shigella released from dead macrophages enter
the surrounding enterocytes through the basolateral sur-
face by inducing macropinocytosis. After a bacterium is
surrounded by the membrane vacuole of an epithelial
cell, it disrupts the vacuolar membrane and escapes into
the cytoplasm. Shigella multiply in the cytoplasm and
move intra- and intercellularly by inducing actin polymeri-
zation at one pole of the bacterium; this polymerization is
required for cell-cell spreading (Cossart and Sansonetti,
2004; Ogawa and Sasakawa, 2006).
While establishing colonization,Shigella deliver a variety
of virulence determinants, and the major determinants,
called effectors, are delivered through the type III secre-
tion system (TTSS) into host cells. For example, after Shi-
gella contact epithelial cells, the TTSS is stimulated and
delivers effectors including IpaA, IpaB, IpaC, IpgB1,
IpgD, and VirA into the host cells; these effectors promote
bacterial invasion of host cells (Ogawa and Sasakawa,
2006; Parsot, 2005). One of these effectors, IpaB, plays
multiple roles in promoting Shigella infection. The IpaB
protein delivered into macrophages activates Caspase-1
and induces cell death (Hilbi et al., 1998, Chen et al.,
1996; Zychlinsky et al., 1992). IpaB also interacts with
CD44 on the epithelial cell membrane and stimulatesCell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc. 611
bacterial basolateral invasion (Lafont et al., 2002). Upon
contact of Shigella with the host plasma membrane,
IpaB, together with IpaC secreted at the tip of the TTSS
needle, acts as a membrane-pore-forming protein, medi-
ating the translocation of effectors via the TTSS into the
host cell cytoplasm (Blocker et al., 1999). IpaB is also de-
livered into the epithelial intracellular compartment during
Shigella infection, but its biological role there is unknown.
The intestinal epithelium self-renews every several
days, providing an important intrinsic defense system
that limits bacterial colonization (Oswald et al., 2005; San-
sonetti, 2004). The fast turnover of intestinal epithelial cells
forms crucial physical as well as functional barriers, and
this renewal is sustained by vigorous proliferation of epi-
thelial progenitors that migrate upwards from the bottom
of the intestinal crypts (Potten, 1998). Indeed, lesions in
the epithelial barrier are quickly repaired; if not, commen-
sal and pathogenic bacteria can enter the wound. Never-
theless, many bacterial pathogens, including Shigella, are
capable of colonizing the intestinal barriers. As mentioned
above, Shigella (as well as many other mucosal Gram-
negative pathogenic bacteria) have developed a variety
of tactics to manipulate host cell functions in order to
avoid or overcome the innate host defense system. Re-
cent studies have indicated that a growing family of bac-
terial toxins and effectors, termed ‘‘cyclomodulins,’’ inter-
fere with the eukaryotic cell cycle, presumably to the
pathogens’ benefit (Oswald et al., 2005). Some of these
cyclomodulins, such as the Cytolethal distending toxin
(CDTs), are produced by a group of unrelated Gram-
negative bacteria that includes S. dysenteriae (Nougayr-
ede et al., 2005). One of the CDTs produced by Campylo-
bacter jejuni possess a deoxyribonuclease I-like activity
and causes limited DNA damage when delivered into
a host cell nucleus, eventually leading to chromatin dis-
ruption (Lara-Tejero and Galan, 2000). Another cyclomo-
dulin, Cycle inhibiting factor (Cif) inhibits host cell mitosis
after transfer from enteropathogenic E. coli via the TTSS
(Marches et al., 2003). Cells transformed by Cif accumu-
late 4n DNA content and reinitiate DNA synthesis without
dividing, resulting in 8–16n DNA content. G2 arrest of the
host cell cycle is associated with the maintenance of
Cdk1, a cyclin-dependent kinase (Cdk), in its premitotic
tyrosine-phosphorylated state (Marches et al., 2003).
However, the mechanisms underlying Cif-mediated
Cdk1 inactivation are unclear. Thus, some cell-cycle inhib-
itors are anticipated to help prolong the pathogen’s pres-
ence by interfering with the rapid turnover of epithelial
cells or by harming the local epithelial barrier, allowing
the entry of pathogenic bacteria into the subepithelial layer
(Lara-Tejero and Galan, 2002).
Cell-cycle progression is stringently controlled by cell-
cycle-specific proteolysis that involves the ubiquitination
of target proteins by two main types of E3 ligase com-
plexes, the anaphase-promoting complex (APC) and the
Skp1-Cullin-F-box protein (SCF) complex (Vodermaier,
2004). The APC is a multisubunit complex that targets
substrates for degradation only during mitosis and G1,612 Cell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc.and it also targets mitotic Cyclin A and Cyclin B1, allowing
mitotic progression. Two proteins, Cdc20 and Cdc20 ho-
molog 1 (Cdh1), bind directly to APC and thereby activate
APC during mitosis and in the late mitotic and G1 phases,
respectively (Peters, 2002). Mad2 and the spindle assem-
bly checkpoint pathway inhibit APCCdc20 activity in re-
sponse to spindle damage (Nasmyth, 2005), and Early
mitotic inhibitor 1 (Emi1) inhibits both Cdc20 and Cdh1
in S and M phases (Hsu et al., 2002; Reimann et al.,
2001a). However, additional APC regulators have been
postulated to exist in order to ensure the destruction of
APC substrates at the correct time and place. Indeed, re-
cent studies have identified p31-comet as a Mad2-binding
partner (Habu et al., 2002). In synchronized HeLa cells,
Mad2 forms a complex with Cdc20 during prometaphase
and metaphase; once the anaphase checkpoint is satis-
fied, the Mad2-Cdc20 complex is dissociated by the bind-
ing of Mad2 to p31-comet. Thus, p31-comet plays a criti-
cal role in relieving inhibition of the Cdc20-containing APC
complex (Xia et al., 2004). Mad2L2, also referred to as
Mad2B or hRev7 (Chen and Fang, 2001; Cheung et al.,
2006; Pfleger et al., 2001) (Mad2L2 hereafter), which
shares 25% amino acid identity and 48% amino acid sim-
ilarity to Mad2, was recently suggested to control APC ac-
tivation by Cdc20 (APCCdc20) and also to suppress APC
activation by Cdh1 (APCCdh1) (Chen and Fang, 2001;
Pfleger et al., 2001). Because Emi1 is capable of sup-
pressing APCCdh1 activation in human cell lines, it is as-
sumed that Mad2L2’s function is similar to that of Emi1
in controlling the APC activation required for the cell-cycle
transition.
In this study we investigated the route of Shigella infec-
tion of the intestinal epithelium using rabbit ileal loops at
various stages of infection and noted that Shigella are ca-
pable of accessing the intestinal crypt after inducing in-
flammatory responses in the intestinal tissue. We found
that the bacterial infection also reduces the proliferation
of epithelial progenitors, as shown by Proliferating cell nu-
clear antigen (PCNA) staining. The effect was absent fol-
lowing innoculation with a TTSS-deficient—and therefore
noninvasive—Shigella mutant, such as the ipaB deletion
mutant. More remarkably, we found that after transfer
from Shigella into epithelial cells, intracellular IpaB can
also be translocated into the host cell nucleus. This obser-
vation led us to further investigate the role of IpaB in Shi-
gella infection of intestinal epithelial cells.
RESULTS
Shigella IpaB Targets Mad2L2 in Epithelial Cells
at G2/M Phase
To explore the role of IpaB delivered into epithelial cells
during Shigella infection of intestine, we performed yeast
two-hybrid screening of HeLa cDNA library and found
that IpaB interacted with Mad2L2, an APC inhibitor
(Figure 1A). Under these conditions, IpaB was incapable
of interacting with other APC inhibitors, such as Emi1
and Mad2 (Figure 1A). The IpaB/Mad2L2 interaction was
Figure 1. IpaB Interacts with Mad2L2
(A) Binding of BD-IpaB1-312, BD-SipB1-319, AD-Mad2L2, AD-IpgC, AD-Emi1-N1-300, AD-Emi1-C250-447, and AD-Mad2 in a yeast two-hybrid
assay.
(B) IpaB bound to Mad2L2 in the GST-pull down assay (top). IpaB1-312 bound to MBP-Mad2L2 in the MBP pull-down assay but not to MBP-Emi1,
MBP-Mad2, or MBP (bottom). Proteins that were pulled down were immunoblotted with antibodies specific for IpaB, IpaC, or IpaD.
(C) Cell lysates from HeLa cells infected with WT/IpaBFLAG were immunoprecipitated with anti-FLAG antibody or mouse IgG, and then immunoblotted
with anti-Mad2L2 or -FLAG antibodies (left). Secretion of IpaBFLAG from Shigella was confirmed using Congo red (CR)-treated supernatants from WT
or WT/IpaBFLAG in immunoblots with anti-IpaB, -IpaC, or -FLAG antibodies (right).confirmed by GST and MBP pull-down assays (Figure 1B).
To test the ability of IpaB to interact with endogenous
Mad2L2 we infected HeLa cells with WT/IpaBFLAG. This
Shigella strain expressed IpaBFLAG from the endogenous
220 kb plasmid (Figure S1A) and carried DdapB so that in-
tracellular Shigella would not kill the host cells in medium
depleted of diaminopimelic acids (DAP). The expressed
IpaBFLAG conferred wild-type TTSS activity (Figure 1C,
right) and invasiveness (Figure S1B). In addition, the strain
expressed AfaE (Afimbrial adhesin E) from E. coli to boost
infection of HeLa cells (Philpott et al., 2000). Twenty-onehours after infection of asynchoronously dividing HeLa
cells, the length of time normally required for a HeLa cell
doubling, Mad2L2 was coimmunoprecipitated with
IpaBFLAG (Figure 1C, left). We next investigated the intra-
cellular locations of IpaB and Mad2L2 in HeLa cells ex-
pressing GFP-IpaB1-312/Myc6-Mad2L2 or GFP-mock/
Myc6-Mad2L2 at the G1/S boundary induced by double
thymidine block (DTB) (Figure 2) Myc6-Mad2L2 and the
GFP control were detected in the nucleus and cytoplasm
from 0 to 15 hr. Although GFP-IpaB1-312 was detected in
the cytoplasm by 3 hr after DTB, IpaB and Mad2L2 wereCell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc. 613
Figure 2. IpaB Localizes in the Nuclei of HeLa Cells during G2/M Phase
GFP-IpaB1-312 and Myc6-Mad2L2 expressed in HeLa cells were visualized after G1/S release. HeLa-expressed GFP and Myc6-Mad2L2 were
similarly examined. Cells were stained with TRITC-labeled anti-Myc antibody and Cy5-labeled anti-APC3 antibody.detected in the nucleus between 6 and 12 hr (Figure 2),
suggesting that IpaB interacts with Mad2L2 in the G2/M
phase.
Mad2, BubR1, Emi1, and RASSF1A are known APC in-
hibitors in humans (Fang et al., 1998; Hsu et al., 2002;
Song et al., 2004; Tang et al., 2001). Since the ability of
Mad2L2 to inhibit APC was previously determined only
in Xenopus (Chen and Fang, 2001; Pfleger et al., 2001),
we generated human anti-Mad2L2 antibody (Figure S2).614 Cell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc.When HeLa cell lysates were immunoprecipitated with
anti-Mad2L2 or -Mad2 antibody, APC3, a component of
APC, was coprecipitated (Figure S3A, upper and bottom).
When HeLa cell lysates were immunoprecipitated with
anti-APC3 antibody Emi1 was coprecipitated (Figure S3A,
middle). To identify the cell-cycle phase involved in the
Mad2L2/APC interaction, HeLa cells synchronized at
the G1/S boundary were lysed at various times after
DTB release and immunoprecipitated with anti-Mad2L2,
Figure 3. Shigella Cause Cell-Cycle Arrest
(A) Rabbit ileal loops 6, 12, and 18 hr after inoculation with 2 3 108 GFP-Shigella were stained with rhodamine-phalloidin (red) and TO-PRO3 (blue).
Bars, 100 mm.
(B) The intestinal tissues were immunostained with FITC-labeled anti-PCNA antibody (green) and counterstained with rhodamine-phalloidin (red) and
TO-PRO3 (blue). Bars, 100 mm.
(C) Spherical HeLa cells after infection with WT, DipaB, or ipaBWT (moi 80) (upper) and their percentages (bottom). *p < 0.0001. Data are represented
as mean ± SEM. Cell-cycle stage distribution was determined by FACS (middle).
(D) Spherical cells among synchronized HeLa cells infected with DipaB or WT (top). *p < 0.0001. Data are represented as mean ± SEM. HeLa spindle
formation was impaired by WT infection but not by DipaB infection. DIC, a-tubulin (green) and DNA (blue). Bars, 10 mm.
(E) Levels of cell-cycle-associated proteins in the cells used for (D) immunoblotting, with the specific antibodies indicated.-APC3, or -Mad2 antibodies. The results showed that
Mad2L2 interacted with APC primarily in G2/M phase
(Figure S3B). The cell-cycle distribution was monitored
by scoring the percentage of spherical cells (Figure S3C)
and using FACS analysis of DNA content (Figure S3D).
Shigella Infection of Epithelial Cells Causes
Unscheduled Activation of APCCdh1
To investigate whether Shigella affect the proliferation of
intestinal epithelial progenitors, YSH6000 (WT/pSU-GFP)
were visualized after inoculation into a rabbit ileal loop
(Figure 3A). Twelve and eighteen hours after inoculation,
WT/pSU-GFP was detected at the bottom of crypts.WT/pSU-GFP or the ipaB mutant (DipaB/pSU-GFP) was
inoculated into rabbit ileal loops, and intestinal tissue
was examined 15 hr later. WT/pSU-GFP, but not DipaB/
pSU-GFP, destroyed the intestinal villi; on the other
hand, PCNA-positive cells in the crypts in Shigella-
infected loops were barely detected (Figure 3B), implying
that Shigella interfer with the proliferation of epithelial
progenitors. HeLa cells were infected with or without
dapB::Km/pIL14-Tp (bacteria expressing AfaE) (WT) in
the presence of DAP for 5 min. When HeLa cells cultured
for 24 hr in DAP-free, gentamicin-containing MEM were in-
fected with WT and ipaBWT/dapB::Km/pIL14-Tp (ipaBWT)
(ipaB complement), approximately 20% of the infectedCell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc. 615
Figure 4. Shigella Cause Premature
Activation of APCCdh1
(A) Analysis of Cyclin B1 ubiquitination activity
in Shigella-infected HeLa cells. APC was im-
munopurified from HeLa cells infected with
WT and then incubated with biotinylated Cyclin
B1 and ubiquitin (Left). Control mouse IgG or
anti-APC3 immunoprecipitates from HeLa
cells infected with WT were immunoblotted
with anti-Cdh1 or -APC3 antibodies (right).
(B) Effect of Shigella ipaB genotype on the
half-lives of APC substrates after inoculation
of asynchronous HeLa cells. Cychloheximide
(CHX, 100 mg/ml) was added, and cell extracts
were prepared at the time points indicated to
investigate the half-lives of Cdc20, Plk1, Cyclin
B1. ND indicates that changes in protein levels
were not detected.
(C) Effect of WT or DipaB infection of synchro-
nous HeLa cells on the half-lives of the APC
substrates.cells, mostly those at G2/M phase, became spherical
(Figure 3C) and TUNEL-negative (data not shown), indicat-
ing that Shigella infection interfers with cell-cycle progres-
sion. This was not the case with DipaB/dapB::Km/pIL14-
Tp (DipaB) (Figure 3C). To characterize the spherical cells,
DTB-synchronized cells at the G1/S boundary were in-
fected with WT or DipaB, and 5 min later the medium
was replaced with DAP-free, gentamicin-containing
MEM. WT infection resulted in more spherical cells than
did DipaB infection (Figure 3D, upper panel). Spherical
cells with condensed chromatin emerged by 12 hr after
infection with the WT bacteria (Figure 3D, lower panel),
whereas the cells generated by DipaB infection had the
metaphase chromosome alignment and spindle organiza-
tion (Figure 3D, lower panel).
Consistent with the results of Figure 2, spherical cells
following WT infection were detected 6 hr after DTB re-
lease (Figure 3D), suggesting that Shigella infection led
to M phase arrest. Immunoblotting of HeLa cells synchro-
nized in G1/S phase showed that although Cyclin B1,
Cdc20, and Plk1 accumulated approximately 9 hr after
DTB release following DipaB infection, they were abol-
ished after WT infection (Figure 3E). WT infection was
also followed by an increase in phosphorylated (active)
APC, as well as a decrease in Cdh1 (an APC activator),
compared with in the conditions followingDipaB infection.
After WT infection, the accumulation of Cdc20 and Plk1,616 Cell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc.known substrates of APCCdh1, but not that of APCCdc20,
was low, and the level of Cdh1 decreased 6 hr after DTB
release of the infected cells, suggesting that APCCdh1 un-
dergoes unscheduled activation by Shigella (Figure 3E).
This notion was also supported by WT Shigella (dapB+) in-
fection of HeLa cells, where the accumulation of Cyclin B1
in WT infection was greatly decreased compared with that
of the noninfection control (Figure S4).
To demonstrate the activation of the APCCdh1 upon WT
infection, we investigated the polyubiquitination level of
Cyclin B1 (Figure 4A, left). Approximately 9 hr after DTB re-
lease, which corresponded to the G2/M phase, APCCdh1
was activated, with the APC interacting with Cdh1 as ex-
amined by immunoprecipitation with anti-APC3 antibody
(Figure 4A, right). Indeed, when the level of APCCdh1 activ-
ity upon WT infection was examined by measuring the
half-lives of APC substrates such as Cdc20, Plk1, and Cy-
clin B1, the half-lives were decreased relative to that of
DipaB infection in either asynchronous (Figure 4B) or syn-
chronous HeLa cells (Figures 4C).
IpaB and Mad2L2 Interaction Causes
the Deregulation of APCCdh1 Activity
To define the IpaB portion involved in Mad2L2 binding, we
performed a yeast two-hybrid assay with various IpaB
truncations and found that Mad2L2 shared a binding site
with IpgC (IpaB chaperone) on IpaB: residues 61–70
Figure 5. IpaB Suppresses Mad2L2 Inhi-
bition of APCCdh1
(A) Mad2L2 bound Cdh1. 293T cells express-
ing GFP-Cdc20, GFP-Cdh1, Myc6-Mad2, or
Myc6-Mad2L2 and treated with Colcemid
32 hr after transfection were lysed 16 hr later
and immunoprecipitated with anti-Myc anti-
body or rabbit IgG and immunoblotted with
anti-GFP, -Mad2, or -Mad2L2 antibodies.
(B) MBP-Mad2L2 bound to Cdc20 and Cdh1.
MBP and MBP-Mad2L2 mixed with 35S-
Cdc20 or 35S-Cdh1 were analyzed on a
BAS2000.
(C) MBP-Mad2L2 binding to 35S-Cdc20 or 35S-
Cdh1 is inhibited by IpaB1-312WT in a dose-
dependent manner.
(D) In vitro ubiquitination assays for purified
APC in the presence or absence of MBP-
Mad2L2 or/and IpaB1-312WT. The APC was
immunopurified from HeLa cell lysates and
activated using recombinant Cdh1. The APC
activated by Cdh1 was incubated with the N-
terminal 100 residues of Cyclin B1-biotin.
(E) The same assay as in (D) but performed with
IpaB1-312N61A.(Figure S5A). Because IpgC acts as the IpaB chaperone
required for IpaB secretion via the TTSS (Page et al.,
2001), we created Gal4 DBD-IpaB1-100 mutants that
bound to AD-IpgC but not to AD-Mad2L2. An IpaB mutant
unable to bind MBP-Mad2L2, N61A (IpaB1-312N61A), was
further investigated (Figures S5B and S5C). By narrowing
down the portions of Mad2L2 used in IpaB-binding exper-
iments, we found that residues 150–211 of Mad2L2 were
involved in the interaction with IpaB (Figure S6).
To examine the interaction between Mad2L2 and Cdh1,
we investigated 293T cells expressing GFP-Cdc20, GFP-
Cdh1, Myc6-Mad2, or Myc6-Mad2L2 and found that more
Cdh1 than Cdc20 was precipitated with Mad2L2
(Figure 5A). When 35S-Cdc20 or 35S-Cdh1 was mixed
with MBP-Mad2L2, Cdh1 and Cdc20 were precipitated
by MBP-Mad2L2, but not by MBP alone (Figure 5B).
When 35S-Cdc20 or 35S-Cdh1 were pulled down after in-
cubation with MBP-Mad2L2 in the presence of IpaB1-
312WT (at 1.5–24 mM), the amounts of 35S-Cdc20 and
35S-Cdh1 bound to MBP-Mad2L2 decreased as the
amounts of IpaB1-312WT increased (Figure 5C), suggest-
ing that the IpaB/Mad2L2 interaction can activate
APCCdh1. Indeed, polyubiquitination of Cyclin B1 by
Cdh1-activated APC was almost completely blocked by
MBP-Mad2L2, but the blockage was absent in the pres-
ence of IpaB1-312WT (Figure 5D). Abrogation of Cyclin
B1 polyubiquitination by MBP-Mad2L2 was not prevented
by IpaB1-312N61A (Figure 5E), adding further evidence that
the IpaB/Mad2L2 interaction promotes unscheduled
APCCdh1 activation.To confirm these findings, HeLa cells transfected with
Mad2L2-RNAi 96 hr prior to synchronization in G1/S
phase were re-transfected with Mad2L2-RNAi immedi-
ately after the first block, and the levels of Cdc20, Plk1,
and Cyclin B1 were examined in cell lysates prepared be-
tween 0 and 15 hr after G1/S release (Figure S7). Although
Luc-RNAi had no effect, Mad2L2 knockdown decreased
the levels of Cdc20, Plk1, and Cyclin B1. The cellular levels
of pHistone H3 were also decreased by Mad2L2-RNAi ap-
proximately 9 hr after DTB release (Figure S7A). In agree-
ment with this, in Luc-RNAi-treated cells the peak of
spherical cells occurred around 9 hr, opposed to a peak
around 12 hr for the Mad2L2-RNAi-treated cells (Fig-
ure S7B). FACS analysis also showed that 12 hr after
DTB release the population at G2/M phase was increased
in cells transfected with Mad2L2-RNAi relative to those
treated with Luc-RNAi (Figure S7C). Indeed, when
pHistone H3-positive cells transfected with Mad2L2-
RNAi were examined by immunostaining approximately
9 hr after DTB release, the percentage of positive cells
was greatly diminished compared with that of cells trans-
fected with the Luc-RNAi control (Figure S7D).
Involvement of the IpaB/Mad2L2 Interaction
in Promoting Bacterial Colonization
of the Intestinal Epithelium
To establish the physiological relevance of IpaB/Mad2L2
interaction to Shigella-directed cell-cycle arrest, we
replaced the ipaB gene of YSH6000 with ipaBN61A
(ipaB::Km::ipaBN61A) and ipaBWT (ipaB::Km::ipaBWT) andCell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc. 617
Figure 6. IpaB/Mad2L2-Dependent Cell-
Cycle Arrest Is Exhibited during Shigella
Infection
(A) The competitive index (1.0, no attenuation)
is a measure of the ability of ipaBN61A to colo-
nize the rabbit ileal loops by comparing with
WT. The competitive infections were carried
out by the following combinations: WT/ipaBWT
(n = 12), WT/ipaBN61A (n = 12), and WT/DipaB
(n = 6). *p < 0.05. Data are represented as
mean ± SEM.
(B) Intestinal tissue immunostained with FITC-
labeled anti-PCNA antibody (green) and coun-
terstained with rhodamine-phalloidin (red) and
TO-PRO3 (blue). Bars, 100 mm.
(C) Time course of transient spherical pheno-
type in synchronized HeLa cells after ipaBWT
or ipaBN61A infection (moi 10). *p < 0.0001.
Data are represented as mean ± SEM.
(D) Lysates of HeLa cells stably expressing
GFP, GFP-IpaB1-312WT, or GFP-IpaB1-
312N61A were immunoprecipitated with anti-
GFP antibody and then immunoblotted with
anti-GFP antibody.
(E) Time course of spherical cell occurrence
among synchronized HeLa cells stably ex-
pressing GFP, GFP-IpaB1-312WT, or GFP-
IpaB1-312N61A. *p < 0.0001. **p < 0.05. Data
are represented as mean ± SEM.
(F) HeLa cells stably transfected with pEGFP,
pEGFP-IpaB1-312WT, or pEGFP-IpaB1-
312N61A were released from thymidine block
at the times indicated. The cell-cycle stages
of the cells were determined by FACS.confirmed that their TTSS activity and invasiveness were
similar (Figures S8A, S8B, and S8C). We also confirmed
that the intracellular stabilities of IpaB and IpaBN61A in syn-
chronized HeLa cells were similar (Figure S8D). We then
prepared a series of bacterial mixtures composed of equal
numbers of YSH6000 (WT)/ipaBWT, WT/ipaBN61A, or
WT/DipaB, each of which were inoculated into rabbit intes-
tinal ileal loops. Eighteen hours after inoculation, we mea-
sured bacterial numbers colonized per 0.5 cm2 of intestinal
tissues. Although WT and ipaBWT colonized to a similar ex-
tent, ipaBN61A showed less colonization (Figure 6A). More-
over, when 2 3 108 CFU of the strains were inoculated
into different ileal loops, ipaBN61A and ipaBWT, but not
YSH6200 (the noninvasive mutant), caused severe inflam-
matory responses accompanying Shigella invasion of the
intestinal tissues 12 hr after inoculation (data not shown).
Importantly, though PCNA-positive cells were rarely seen
in the cryptic area after infection with ipaBWT, many were
observed after infection with ipaBN61A (Figure 6B), indicat-
ing that the IpaB/Mad2L2 interaction is important for pro-
moting Shigella infection. When HeLa cells synchronized
by DTB release were infected by Shigella carrying ipaBWT618 Cell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc.or ipaBN61A, the percentage of spherical cells at 12 hr after
release was lower with ipaBN61A than with ipaBWT (Fig-
ure 6C). Furthermore, when HeLa cells stably expressing
GFP, GFP-IpaB1-312WT, or GFP-IpaB1-312N61A were
synchronized to the G1/S phase by DTB, after release the
percentage of spherical cells was higher among cells ex-
pressing GFP-IpaB1-312WT than those expressing GFP-
IpaBN61A (Figure 6E). To confirm this, HeLa cells stably ex-
pressing GFP, GFP-IpaB1-312WT, or GFP-IpaB1-312N61A
were synchronized in the G1/S phase by DTB, and after
release, the cells that had incorporated bromodeoxyuri-
dine (BrdU) into their nuclei were identified by anti-BrdU-
FITC antibody (representing S phase cells) and propidium
iodide (PI) staining (representingG1 and G2/M phasecells).
Although the numbers of S- and G2/M-phased cells ex-
pressing GFP mock and GFP-IpaB1-312N61A were similar,
there were more such cells in cells expressing GFP-IpaB1-
312WT 12–15 hr after DTB release (Figure 6F). Thus, this se-
ries of experiments strongly suggested that the retardation
of rapid intestinal epithelial renewal, due to the interaction
of IpaB/Mad2L2 during Shigella infection, is pivotal to pro-
longing colonization within the intestinal epithelium.
DISCUSSION
In the present study, we have provided convincing in vitro
and in vivo evidence that Shigella can modulate the cell-
cycle progression of intestinal epithelial cells, and that
the IpaB effector delivered via the TTSS into a host cell in-
teracts with Mad2L2. This bacterial capability appears to
affect epithelial cell turnover by slowing down cell renewal
during infection, enabling Shigella to persist longer in its
replicative niche.
The IpaB/Mad2L2 Interaction Activates APCCdh1
at G2/M Phase
Mad2L2 was previously reported to be a Mad2-related
protein capable of binding APCCdh1 and inhibiting
APCCdh1 activation, though the precise role of Mad2L2
in modulating cell-cycle progression remains to be eluci-
dated. Studies indicated that Mad2L2 plays a pivotal
role in translesional DNA synthesis (TLS) in S phase cells
(Cheung et al., 2006; Murakumo et al., 2006), and that it
also participates in the spindle assembly checkpoint, sim-
ilarly to Mad2 (Reimann et al., 2001b). In the present study,
however, we did not observe GFP-IpaB1-312 within the
nucleus in S phase HeLa cells, implying that IpaB is not in-
volved in TLS. Since IpaB lacks a nuclear localization sig-
nal (NLS) and, at 62.2 kDa, is probably too large to enter
the nucleus via passive diffusion, we speculate that its en-
try into the nucleus may occur by complex formation with
Mad2L2, which does possess a putative NLS. Mad2L2
shares significant amino acid identity (25%) and similarity
(48%) with Mad2 (Cahill et al., 1999). More recent studies
have indicated that Mad2L2 can suppress the activation
of APCCdh1 (Pfleger et al., 2001). Emi1 is also known to
suppress APCCdh1 activation at G1/S phase, suggesting
that Mad2L2 shows activity similar to Emi1 (Hsu et al.,
2002). APC activation by Cdc20 is predominant at M
phase, at which point the Mad2/Cdc20 interaction sup-
presses APC activation, while at M/G1 phase APC can
be activated by Cdh1 (Peters, 2002). Mad2L2 is predom-
inantly localized within the nuclei of BHK cells (Pfleger
et al., 2001), and APC is also detected in the nuclei, sug-
gesting that the Mad2L2 is able to influence APC activity
at M/G1 phase. The activity of APCCdh1 decreases at S
phase (Bashir et al., 2004; Wei et al., 2004), at which point
Emi1 participates in the inhibition of APC (Hsu et al., 2002),
raising the possibility that Mad2L2 also takes part in acti-
vating APC at either S or G2/M phase. Therefore, using
cell lysates prepared from HeLa cells synchronized at
G1/S phase, we investigated whether Mad2L2 could con-
trol APC activity in M/G1, S, or G2/M phase. Our results of
the immunoprecipitation assay with anti-Mad2L2 anti-
body clearly indicated that Mad2L2 does interact with
APC in HeLa cells at G2/M phase (Figure S3B). Consis-
tently, when GFP-IpaB1-312 and Myc6-Mad2L2 were ec-
topically expressed in synchronized HeLa cells, both sig-
nals were detected within the nuclei at G2/M phase
(Figure 2). Taken together, our results indicate that theIpaB/Mad2L2 interaction participates in the activation of
APCCdh1 at G2/M phase during Shigella infection.
Shigella Infection of Epithelial Cells Causes
Cell-Cycle Arrest
The intestinal epithelium self-renews every few days, and
its rapid turnover (including the tight sealing of epithelial
cell-cell junctions) is the most important intrinsic host de-
fense against bacterial colonization. The ability of Shigella
IpaB to inhibit cell-cycle progression thus seems to be
a bacterial strategy to prolong local persistence by block-
ing epithelial shedding. In addition, impairing the intestinal
epithelial integrity, which also occurs as a consequence of
cell-cycle progression inhibition (Nougayrede et al., 2005;
Oswald et al., 2005), might further contribute to bacterial
entry from the basolateral surface of epithelial cells, also
promoting bacterial colonization. Because at its initial
stages Shigella infection of intestinal epithelium takes
place via the M cells, and the bacterial ability to slow
cell-cycle progression was also anticipated to be less
effective on well-differentiated superficial epithelial cells
(Sansonetti, 2004), we pursued whether Shigella could di-
rectly access the intestinal cryptic area that is abundant in
epithelial progenitors. Using a rabbit ileal loop infection
model (Figure 3A) and a guinea pig rectal infection model
(Shim et al., 2007), we have shown that Shigella infection
can enter crypts and infect the cryptic epithelium by
12 hr post-infection (Figure 3A). At that stage, though we
detected few epithelial progenitors after WT Shigella
infection, epithelial progenitors remained abundant after
infection with the ipaB mutant (Figure 3B). Likewise, the
ability of Shigella to induce cell-cycle arrest could be re-
produced using synchronized HeLa cells infected with
WT but not ipaB mutant bacteria (Figure 3D). WT Shigella
infection of HeLa cells generated more spherical cells with
condensed chromatin than did the ipaB mutant 6 hr after
G1/S release; furthermore, the spherical cells were TUNEL
negative, implying that the spherical cells were not a con-
sequence of apoptosis. Indeed, because the spherical
HeLa cells caused byShigella infection showed poor spin-
dle formation, we assumed that the cell-cycle arrest
caused in the infected HeLa cells occurred prior to meta-
phase. Thus our data indicate that IpaB plays an important
role in causing cell-cycle arrest, although we have not ex-
cluded the possibility that other Shigella proteins might
also play a role in affecting cell-cycle progression.
Shigella Infection of Epithelial Cells Preferentially
Activates APCCdh1
If the activation of APC in HeLa cells truly occurred as
a consequence of the IpaB/Mad2L2 interaction during
Shigella infection, one would anticipate that the degrada-
tion of APCCdh1 substrates would also take place. We
therefore investigated the levels of Cyclin B1, Cdc20,
and Plk1, known substrates for APCCdh1 and, to a lesser
extent, for APCCdc20. Indeed, the levels of Cyclin B1,
Cdc20, and Plk1 in HeLa cells 9 hr after G1/S release un-
derwent degradation after infecting with WT but not withCell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc. 619
Figure 7. Proposed Model of the Role of
IpaB in Cell-Cycle Progression Interfer-
ence
Mad2L2 interaction with APCCdh1 increases
during G2/M (Figure S3B) and could therefore
result in the accumulation of Cyclin B1,
Cdc20, and Plk1 in G2/M (Figure S7A). Un-
scheduled activation of APCCdh1 in G2/M by
IpaB (Figure 3E) could explain the mitotic ab-
normalities inShigella-infected cells (Figure 3D)
and, in turn, leads to premature degradation of
Cyclin B1, Cdc20, and Plk1, a delay in mitotic
progression, and faulty mitosis.the ipaB mutant Shigella (Figure 3E). As Cdc20 and Plk1
are substrates for APCCdh1 but not APCCdc20 (Castro
et al., 2005), the above results suggest that APCCdh1 acti-
vation, but not that of APCCdc20, occurred as the Shigella-
induced unscheduled activation. In this regard, it is worth
noting that Shigella infection had a smaller effect on the
levels of Cyclin A than those of Cyclin B1, Cdc20, or
Plk1 (Figure 3E). The fact that Cyclin A is an APCCdh1 sub-
strate, and its rate of degradation is slower than that of
other APCCdh1 substrates (Rape et al., 2006), may explain
Shigella infection’s smaller effect on Cyclin A degradation
than on the other APCCdh1 substrates. In any case, our re-
sults strongly indicate that an unscheduled activation of
APCCdh1 takes place in HeLa cells at G2/M phase follow-
ing Shigella infection (Figure 4).
In addition to the activation of APC by Cdc20 and Cdh1,
the activation of APC is also accompanied by phosphory-
lation of APC3 (Kraft et al., 2003), an APC subunit, by other
host factors. Knockout or -down of Mad2 causes early sis-
ter chromatid segregation in the presence of spindle for-620 Cell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc.mation inhibitor (Michel et al., 2001, 2004; De Antoni
et al., 2005; Luo et al., 2004). In contrast, knockdown of
Mad2L2 results in a delay in cell-cycle progression (see
Figure S7C). Although Mad2 also contributes to a delay
in cell-cycle progression, Mad2L2 can promote cell cy-
cling as do APC inhibitors such as Emi1 and RASSF1A
(Hsu et al., 2002; Song et al., 2004). Importantly, upon Shi-
gella infection of HeLa cells, the phosphorylation of APC3
was also detected, though the result was not dramatic
(Figure 3E). Although we do not understand how APC3
phosphorylation is stimulated by Shigella infection, be-
cause the levels of Cyclin B1 and Plk1 were greatly de-
creased, the upregulation of phosphorylated APC3 does
not seem to be mediated by Cyclin B1-dependent or
Plk1 kinase; rather, other uncharacterized factor(s) may
be involved in the phosphorylation of APC3. In HeLa cells
infected with WT but not with ipaB mutant Shigella, the
levels of Cdh1 were also remarkably decreased
(Figure 3E). As Cdh1 has been shown to undergo degra-
dation by APCCdh1 at G0 or G1 phase (Listovsky et al.,
2004), the decrease in Cdh1 after Shigella infection is also
consistent with bacterial infection-induced unscheduled
activation of APCCdh1.
How Does Host Cell-Cycle Arrest by Shigella
Contribute to Bacterial Colonization?
The present study demonstrates that the cell-cycle pro-
gression modulated by APC’s ubiquitin ligase activity
can be slowed by the delivery of IpaB by Shigella into
the host cells. How does this activity contribute to the bac-
terial colonization of the intestinal epithelium? As noted
above, as the rapid turnover of epithelial layers limits bac-
terial colonization, it is possible that slowing this turnover
could prolong Shigella’s replicative foothold. Although the
situation is different than with Shigella, a similar hypothe-
sis was recently postulated for Trichuris trichuria, a cecal-
dwelling parasitic nematode. In the case of Trichuris, an
increase in the rate of epithelial cell turnover in murine
large intestines acted as an ‘‘epithelial escalator’’ to effi-
ciently expel Trichuris (Cliffe et al., 2005). To investigate
this idea, we created IpaBN61A, a single amino acid-
substituted IpaB mutant, which interacts more weakly
with Mad2L2 (Figure S5) but still functions as a TTSS
translocator (Figures S8A and S8B) and supports bacterial
invasion of epithelial cells (Figure S8C). We compared this
mutant’s ability to deregulate APC activity via Mad2L2 to
that of WT IpaB in a Cyclin B1 ubiquitination assay. The
results clearly showed that the inhibition of APCCdh1 by
Mad2L2, as examined by the Cyclin B1 ubiquitination
level, was reduced by the addition of IpaB but not
IpaBN61A into the assay medium (Figures 5D and 5E). Im-
portantly, when a bacteria mixture composed of an equal
number of Shigella expressing IpaB and Shigella express-
ing IpaBN61A was inoculated into rabbit ileal loops, the col-
onization rate of Shigella expressing IpaB was much
more efficient than that of Shigella expressing IpaBN61A
(Figure 6A), further supporting the idea that the IpaB/
Mad2L2 interaction is functionally important for bacterial
colonization. In further support of our hypothesis, it has
become increasingly evident that certain cyclomodulins,
bacterial toxins, and effectors that modulate the eukary-
otic cell cycle can target epithelial cells and control their
cell-cycle progression (Nougayrede et al., 2005; Oswald
et al., 2005). For example, Cytolethal-distending toxin
(CDT), which is produced by a group of unrelated Gram-
negative pathogenic bacteria, causes cell-cycle arrest in
epithelial cells, though the targeted phase of the cell cycle
varies between cell types (Lara-Tejero and Galan, 2000;
Whitehouse et al., 1998). In these studies, the ability of
CDT to cause cell-cycle arrest raises the possibility that
prolonging local bacterial existence can be achieved by
slowing epithelial renewal.
In summary, our study has provided convincing evi-
dence that Shigella influence epithelial cell-cycle progres-
sion by delivering IpaB into host cells. Once inside, IpaB
interferes with the binding of Mad2L2 to Cdh1, leading
to unscheduled activation of APC and subsequent Cyclin
B1 degradation (Figure 7). We conclude that the retarda-tion of intestinal epithelial renewal during Shigella infection
prolongs bacterial colonization of the intestinal epithelium.
To our knowledge, this is the first evidence that a bacterial
TTSS-mediated effector, IpaB, targets epithelial cells and
directly modulates their cell-cycle progression by target-
ing the activity of APC.
EXPERIMENTAL PROCEDURES
Yeast Two-Hybrid Assay
The yeast two-hybrid screen was performed with the Matchmaker
GAL4 Two-Hybrid System 3 (Clontech), AH109 cotransformed with
pGBKT7-ipaB1-936, a GAL4 DNA-binding domain vector, and
a HeLa cDNA library cloned into a GAL4 activation domain vector,
pACT2.
Pull-Down Assays
GST-Mad2L2 bound to glutathione sepharose 4B was mixed with re-
combinant IpaB for 2 hr at 4C. After centrifugation, the beads were
washed three times with 1% Triton X-100-PBS and immunoblotted.
The MBP-Mad2L2 bound to the amylose resin was mixed with re-
combinant IpaB derivatives or 35S-labeled proteins and incubated
for 2 hr at 4C. Following centrifugation, the supernatant was dis-
carded and the beads were subjected to immunoblotting after washing
with 0.1% Tween 20-PBS eight times.
Coimmunoprecipitations
In our endogenous coimmunoprecipitation experiments, HeLa lysates
were spun at 15,000 rpm for 15 min at 4C. After adding 2 mg of
primary antibody (anti-Mad2, -APC3, or -Mad2L2 antibodies)-protein
G-sepharose complex to the lysates, they were placed on ice for
2 hr. Mouse IgG was used as a negative control. Immunoprecipitates
were washed three times with lysis buffer and then subjected to
immunoblotting.
Cell Synchronization
HeLa G1/S cells were prepared by double thymidine block (DTB). The
cells were first arrested with 2.0 mM thymidine for 20 hr, released into
thymidine-free medium for 8 hr, and arrested again by incubation in
2.0 mM thymidine for 16 hr. Synchronous mitotic cells were obtained
by incubating for 16 hr in medium containing Colcemid (Demecolcine,
Sigma) at 150 ng/ml.
RNAi
A small interfering RNA (CAGAAACGCAAGAAGUACA) duplex specific
for Mad2L2 repression was transfected into cells using Oligofect-
AMINE (Invitrogen), according to the manufacturer’s instructions.
Immunohistochemical Staining for PCNA
To identify PCNA-positive crypt cells in the rabbit intestine, tissue
specimens fixed with 4% paraformaldehyde in PBS were frozen in liq-
uid nitrogen and sectioned by a Leica cryostat (model CM 1900). The
sections were fixed for 4 min in acetone at 4C and then air-dried at
room temperature. Sections were prepared and placed in 10 mM so-
dium citrate buffer (pH 6.0), which was brought to a boil in a microwave
oven, and the sections were allowed to cool to room temperature. The
tissue was neutralized by two rinses in PBS-0.5% Tween 20 (PBS-T).
The sections were blocked for 30 min with PBS (pH 7.4) containing
10% goat serum and incubated with primary antibody (anti-PCNA,
PC10) at a dilution of 1:100 in the above medium for 60 min. The sec-
tions were then rinsed in PBS-T and incubated with secondary anti-
body (anti-mouse IgG-FITC, 1:100) for 60 min.
Ubiquitination Assay
The ubiquitination assay was carried out as previously described (Ko-
tani et al., 1998). The N terminus of human Cyclin B1 cDNA, encodingCell 130, 611–623, August 24, 2007 ª2007 Elsevier Inc. 621
amino acid residues 1–100, was inserted into the BamHI-XhoI site of
pET21a or NdeI site of pET42a and expressed in BL21 cells. The
His-tagged recombinant Cyclin B1 protein was purified and biotiny-
lated using a kit (Pierce). The purified APC was mixed in 30 ml of
10 mM Tris (pH 7.6), 0.5 mM MgCl2, 1.5 mM DTT, 10 mM ATP, 5 mg
recombinant E1, 1 mg/ml recombinant E2hC, 1 mg/ml recombinant
E2H5B, 20 mg/ml ubiquitin (Sigma), 1 mg/ml recombinant Cdh1, and
10 mg/ml biotinylated Cyclin B1 and then incubated at 25C for 30 min.
Competitive Colonization Assay
Rabbit ileal loops were inoculated with 0.5 ml of a mixture (approxi-
mately 1:1) of WT (KmS) and ipaB mutant (KmR) Shigella (total inocu-
lum, 4 3 108 CFU in PBS), and each loop was treated twice with
PBS containing 50 mg/ml gentamicin. Similar-sized tissue specimens
obtained with an 8 mm diameter biopsy punch were washed with
PBS to eliminate residual gentamicin. The tissue samples were then
ground in ice-cold PBS, and a 1/10 dilution was prepared in tryptic
soy broth (TCS) and incubated for 30 min at 37C with aeration. Serial
dilutions of this culture were then plated on agar and incubated over-
night at 37C. CFUs were counted and the number of bacteria was
calculated per 0.5 cm2 of intestinal tissue.
Flow Cytometry
Cell-cycle distribution was determined by propidium iodide (PI) or
PI/BrdU double staining. For PI/BrdU double staining, BrdU was
added to the culture medium 30 min prior to harvesting. BrdU incorpo-
ration was detected with a FITC-labeled mouse anti-BrdU antibody,
and both DNA content and BrdU incorporation were analyzed by
a FACSCalibur flow cytometer.
Statistical Analysis
Values are reported as means ± standard error of the mean. p values
were calculated by using a nonparametric one-tailed Mann-Whitney
U-test.
Supplemental Data
Supplemental Data include Experimental Procedures, eight figures,
and Supplemental References and are available with this article online
at http://www.cell.com/cgi/content/full/130/4/611/DC1/.
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